tangeretin has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CC; Chen, GJ; Cheng, YP; Chuang, WL; Li, CH; Li, S; Lin, PY; Or, CR | 1 |
| Ma, LL; Wang, DW; Yu, XD; Zhou, YL | 1 |
| Christidou, M; Dexter, DT; Kandanearatchi, A; Maidment, SL; Pilkington, GJ; Rooprai, HK; Rucklidge, GJ; Trillo-Pazos, G; Widmer, W | 1 |
3 other study(ies) available for tangeretin and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4'-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Cell Line; Cell Line, Tumor; Cell Survival; Flavones; Glioblastoma; Humans; Interleukin-6; Open Reading Frames; STAT3 Transcription Factor | 2019 |
Tangeretin induces cell cycle arrest and apoptosis through upregulation of PTEN expression in glioma cells.
Topics: Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flavones; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; PTEN Phosphohydrolase; RNA, Messenger; Time Factors; Up-Regulation | 2016 |
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Captopril; Cell Adhesion; Cell Movement; Cell Survival; Collagen; Drug Evaluation, Preclinical; Ependymoma; Flavones; Flavonoids; Glioblastoma; Humans; Inhibitory Concentration 50; Matrix Metalloproteinases; Neoplasm Invasiveness; Swainsonine; Tumor Cells, Cultured | 2001 |